These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 18212563

  • 1. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
    Dietrich W, Busley R, Boulesteix AL.
    Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
    [Abstract] [Full Text] [Related]

  • 2. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND.
    Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [Abstract] [Full Text] [Related]

  • 3. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 4. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA, Evans FM, Rosenberg ES, Fazlollah TM, Baker MJ, Wilson EC, Kaiser AM, Tosone SR, Miller BE.
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [Abstract] [Full Text] [Related]

  • 5. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D, Howell NJ, Freemantle N, Cunningham D, Bonser RS, Graham TR, Mascaro J, Rooney SJ, Wilson IC, Cramb R, Keogh BE.
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 9. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A, Jooste EH, Kuch BA, Lichtenstein SE, Morell V, Munoz R, Ellis D, Davis PJ.
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [Abstract] [Full Text] [Related]

  • 10. Aprotinin and renal dysfunction after pediatric cardiac surgery.
    Székely A, Sápi E, Breuer T, Kertai MD, Bodor G, Vargha P, Szatmári A.
    Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
    [Abstract] [Full Text] [Related]

  • 11. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
    Lindvall G, Sartipy U, Ivert T, van der Linden J.
    Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
    [Abstract] [Full Text] [Related]

  • 12. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
    Backer CL, Kelle AM, Stewart RD, Suresh SC, Ali FN, Cohn RA, Seshadri R, Mavroudis C.
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
    [Abstract] [Full Text] [Related]

  • 13. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT.
    Am J Nephrol; 2008 Dec; 28(4):576-82. PubMed ID: 18264006
    [Abstract] [Full Text] [Related]

  • 14. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
    Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Li L, Hu S.
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
    [Abstract] [Full Text] [Related]

  • 15. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
    Jakobsen CJ, Søndergaard F, Hjortdal VE, Johnsen SP.
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
    [Abstract] [Full Text] [Related]

  • 16. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF.
    N Engl J Med; 2008 Feb 21; 358(8):784-93. PubMed ID: 18287601
    [Abstract] [Full Text] [Related]

  • 17. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.
    Tolpin DA, Collard CD, Lee VV, Elayda MA, Pan W.
    J Thorac Cardiovasc Surg; 2009 Oct 21; 138(4):873-9. PubMed ID: 19660351
    [Abstract] [Full Text] [Related]

  • 18. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ, Griesdale DE, Schneeweiss S.
    Pharmacoepidemiol Drug Saf; 2009 Apr 21; 18(4):259-68. PubMed ID: 19185048
    [Abstract] [Full Text] [Related]

  • 19. Slightly elevated serum creatinine predicts renal failure requiring hemofiltration after cardiac surgery.
    Kilo J, Margreiter JE, Ruttmann E, Laufer G, Bonatti JO.
    Heart Surg Forum; 2005 Apr 21; 8(1):E34-8. PubMed ID: 15769711
    [Abstract] [Full Text] [Related]

  • 20. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients.
    Rahmanian PB, Adams DH, Castillo JG, Vassalotti J, Filsoufi F.
    J Thorac Cardiovasc Surg; 2008 Apr 21; 135(4):915-22. PubMed ID: 18374780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.